Home/Filings/4/0000919574-20-002503
4//SEC Filing

Broadfin Healthcare Master Fund Ltd 4

Accession 0000919574-20-002503

CIK 0001103021other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 5:45 PM ET

Size

12.2 KB

Accession

0000919574-20-002503

Insider Transaction Report

Form 4
Period: 2020-03-17
Transactions
  • Exercise/Conversion

    Common Stock

    2020-03-17$2.93/sh10,623$31,1254,310,689 total(indirect: See footnote)
  • Conversion

    Options

    2020-03-1710,62337,500 total(indirect: See footnote)
    Exercise: $2.93From: 2020-03-17Common Stock (10,623 underlying)
Footnotes (2)
  • [F1]The securities are held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Each of Broadfin Capital, LLC, Broadfin Healthcare Master Fund, Ltd. and Kevin Kotler disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and affirmatively disclaim being a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
  • [F2]On August 1, 2018, the Issuer awarded to Mr. Kotler options ("Options") to purchase 48,123 Shares at an exercise price of $2.93 per share as compensation for his service on the Issuer's board of directors. Options have vested as follows: (i) 1,562 Options vested in the first open window following the filing of the Issuer's quarterly 10-Q for June 30, 2018; (ii) 9,061 Options vested in the first open window following the Issuer's 2019 Annual Meeting of Stockholders; and (iii) 15,000 Options vest in the first open window following the Issuer's 2020 Annual Meeting of Stockholders. The remaining Options vest as follows: (i) 15,000 Options vest in the first open window following the Issuer's 2021 Annual Meeting of Stockholders; and (ii) 7,500 Options vest in the first open window following the Issuer's 2022 Annual Meeting of Stockholders. The Options expire on August 1, 2028.

Documents

1 file

Issuer

BIODELIVERY SCIENCES INTERNATIONAL INC

CIK 0001103021

Entity typeother

Related Parties

1
  • filerCIK 0001511900

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 5:45 PM ET
Size
12.2 KB